Abstract:RNA-binding proteins (RBPs) control mRNA processing, stability, transport, editing, and translation. We recently conducted transcriptome analyses comparing normal (i. e., healthy) cervical tissue samples with human papillomavirus (HPV)-positive cervical cancer tissue samples and identified 614 differentially expressed protein-coding transcripts which are enriched in cancer-related pathways and consist of 95 known RBPs. We verified the altered expression of 26 genes with a cohort of 72 cervical samples, including 24 normal cervical samples, 25 cervical intraepithelial neoplasia grade 2 (CIN2) and CIN3 samples, and 23 cervical cancer tissue samples. LY6K (lymphocyte antigen 6 complex locus K), FAM83A (family member with sequence similarity 83), CELSR3, ASF1B, IQGAP3, SEMA3F, CLDN10, MSX1, CXCL5, ASRGL1, ELAVL2, GRB7, KHSRP, NOVA1, PTBP1, and RNASEH2A were identified as novel candidate genes associated with cervical lesion progression and carcinogenesis. HPV16 or HPV18 infection was found to alter the expression of 8 RBP genes (CDKN2A, ELAVL2, GRB7, HSPB1, KHSRP, NOVA1, PTBP1, and RNASEH2A) in human vaginal and foreskin keratinocytes. Both viral E6 and E7 decreased NOVA1 expression, but only E7 increased the expression of RNASEH2A in an E2F1-dependent manner. Proliferating cell nuclear antigen (PCNA) directs RNASEH2 activity with respect to DNA replication by removing the RNA primers to promote Okazaki fragment maturation, and two factors are closely associated with neoplasia progression. Therefore, we predict that the induction of expression of RNASEH2A via viral E7 and E2F1 may promote DNA replication and cancer cell proliferation. IMPORTANCE High-risk HPV infections lead to development of cervical cancer. This study identified the differential expression of 16 novel genes (LY6K, FAM83A, CELSR3, ASF1B, IQGAP3, SEMA3F, CLDN10, MSX1, CXCL5, ASRGL1, ELAVL2, GRB7, KHSRP, NOVA1, PTBP1, and RNASEH2A) in HPV-infected cervical tissue samples and keratinocytes. Eight of these genes (CDKN2A, ELAVL2, GRB7, HSPB1, KHSRP, NOVA1, PTBP1, and RNASEH2A) encode RNA-binding proteins. Further studies indicated that both HPV16 and HPV18 infections lead to the aberrant expression of selected RBPencoding genes. We found that viral E6 and E7 decrease NOVA1 expression but that E7 increases RNASEH2A expression via E2F1. The altered expression of these genes may be utilized as biomarkers for high-risk (HR)-HPV carcinogenesis and progression.

Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1

The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle.

Regulation of Bovine Papillomavirus Type 1 Gene Expression by RNA Processing

A Transcriptomic Landscape of Human Papillomavirus 16 E6‐regulated Gene Expression and Splicing Events

RNA elements that control human papillomavirus mRNA splicing‐targets for therapy?

Specific Interaction Between Hnrnp H and HPV16 L1 Proteins: Implications for Late Gene Auto-Regulation Enabling Rapid Viral Capsid Protein Production.

Alteration of RNA M6a Methylation Mediates Aberrant RNA Binding Protein Expression and Alternative Splicing in Condyloma Acuminatum

HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered

hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6^E7 mRNAs via GGG motifs

A Point Mutation in the DNA-binding Domain of HPV-2 E2 Protein Increases Its DNA-binding Capacity and Reverses Its Transcriptional Regulatory Activity on the Viral Early Promoter.

Alternative splicing in the genome of HPV and its regulation

Hpv-2 Isolates from Patients with Huge Verrucae Vulgaris Possess Stronger Promoter Activities

PRMT1 Modulates Alternative Splicing to Enhance HPV18 mRNA Stability and Promote the Establishment of Infection

Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation

Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression

Viral Dna Replication Orientation and Hnrnps Regulate Transcription of the Human Papillomavirus 18 Late Promoter

Human Papillomavirus Type 16 E2 and E6 Are RNA-binding Proteins and Inhibit in Vitro Splicing of Pre-Mrnas with Suboptimal Splice Sites

MiR-875 and Mir-3144 Switch the Human Papillomavirus 16 E6/E6* Mrna Ratio Through the EGFR Pathway and a Direct Targeting Effect.

RbAp48 Is a Critical Mediator Controlling the Transforming Activity of Human Papillomavirus Type 16 in Cervical Cancer